Navigation Links
A new disease: couch potato: needs drug therapy

Couch potato is a layman word for “Extreme laziness” which is a medical condition called motivational deficiency disorder (MoDeD). This was told by Australian researchers in a report in the 1 April issue of the British Medical Journal (BMJ) // Professor Leth Argos, a neuroscientist at the University of Newcastle, reportedly identified the new disorder.

In severe cases it can be fatal because the condition reduces the motivation to breathe, his report adds. It's diagnosed using a combination of positron emission tomography and low scores on a motivation rating scale, previously validated in elite athletes. Drug therapy involves treatment by various drugs.

An Australian biotechnology company called Healthtec, advised by Argos, has had promising trial results of the new drug indolebant, and designed to help people with the condition, as Moynihan "One young man who could not leave his sofa is now working as an investment adviser in Sydney."

Professor David Henry of the University of Newcastle says, “While some extreme sufferers of MoDeD may benefit from indolebant, common laziness is not a disease. Some people might have a genuinely debilitating form of MoDeD but others are just plain lazy and have "an absolute right to just sit there.”

Moynihan is critical of the role of Healthtec's promotion of MoDeD and what he calls the “corporate-sponsored creation of illness".

Moynihan says, “In almost any condition you take there are people at the severe end of the spectrum who benefit greatly from a medical label and from therapy including medication. I think that people who react negatively to this debate about disease mongering do a disservice to the genuinely ill."

'"/>




Page: 1

Related medicine news :

1. Stem cell cure for peripheral vascular disease: New hope on the horizon
2. Heart disease: Men Are From Mars, Women From Venus
3. Another dietary medicine for Alzheimer’s disease: Red cabbage
4. A potato (couch or not) in the diet adverse for diabetics.
5. Couch potato parents make couch potato kids!
6. Body mass index guide needs revision
7. Risk of heart disease prediction needs updating
8. Air pollution combined with greater medical needs
9. Treatment of postpartum depression needs to be personalized
10. FDA needs to be more vigilant in monitoring, tissue banks.
11. Australia: Salt needs More of Iodine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology: